Skip to main content
. 2021 Apr 1;4(5):e1376. doi: 10.1002/cnr2.1376

TABLE 1.

Patient characteristics

Characteristics All N (%) IOERT/HWBI N (%) CWBI/EETBB N (%) p Value
Involvement side
Left 37 (61.7) 19 (63.3) 18 (60) .79
Right 23 (38.3) 11 (36.7) 12 (40)
Grade
I 15 (25) 10 (33.3) 5 (16.7) .28
II 17 (48.3) 12 (40) 17 (56.7)
III 16 (26.7) 8 (26.7) 8 (26.7)
pT stage
T1 25 (41.7) 18 (60) 7 (23.3) .0004
T2 35 (58.3) 12 (40) 23 (76.7)
pN stage
N0 49 (81.7) 20 (66.7) 29 (96.7) .003
N1 11 (18.3) 10 (33.3) 1 (3.3)
pStage
I 19 (31.7) 12 (40) 7 (23.3) .16
II 41 (6.3) 18 (60) 23 (76.7)
ER status
3 (5) 0 (0) 3 (10) .07
+ 57 (95) 30 (100) 27 (90)
PR status
13 (21.7) 8 (26.7) 5 (16.7) .34
+ 47 (78.3) 22 (73.3) 25 (83.3)
Her2 status
48 (80) 22 (73.3) 26 (86.7) .19
+ 12 (20) 8 (267) 4 (13.3)
Ki67
14%> 15 (25) 8 (26.7) 7 (23.3) .76
14%< 45 (75) 22 (73.3) 23 (76.7)